Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 4,077 | 3,365 | 4,198 | 4,625 | 7,897 |
| Operating Income | -4,077 | -3,365 | -4,198 | -4,625 | -7,897 |
| Interest Expense | 1,988 | 1,939 | 1,820 | 1,826 | 1,744 |
| Other Income | 1,019 | -196 | -2,166 | -1,070 | 10 |
| Pre-tax Income | -5,046 | -5,500 | -8,184 | -7,521 | -9,631 |
| Net Income Continuous | -5,046 | -5,500 | -8,184 | -7,521 | -9,631 |
| Net Income | $-5,046 | $-5,500 | $-8,184 | $-7,521 | $-9,631 |
| EPS Basic Total Ops | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 |
| EPS Diluted Total Ops | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.08 | -0.13 | -0.12 | -0.15 |
| EBITDA(a) | $-4,065 | $-3,324 | $-4,198 | $-4,623 | $-7,887 |